REGN : Insider Transactions for Regeneron Pharmaceuticals Inc | J3SG

Sign in:	Email	Password save:

		Company Reports
Find Symbol

Recent: Companies Filers Institutions

Membership is free, please Sign Up.

My Recent Searches

Help

Roster

Institutions

Add To Portfolo/Alerts

Get Insiders for :

Regeneron Pharmaceuticals Inc (REGN)

$1,051.03

0.17 (0.02%) as of 4:30 Fri 6/28

Download

Exchange:

Nasdaq National Market

Security Type:

Common

Shares Out:

104,690,000

Market Cap:

110.03(B)

Last Volume:

750,617

Avg Vol:

759,306

52 Week Range:

$692.45 - $1071.19

Level I Sector:

Health Care

Level II Sector:

Drugs

Level III Sector:

Biotechnology

Member Indexes:

	S&P COMPOSITE 1500		NASDAQ BIOTECHNOLOGY
	NASDAQ COMPOSITE		S&P SMALLCAP 600
	NASDAQ NNM COMPOSITE

Rankings:

Insider 3 Months : -

Insider 6 Months : -

Insider 3/6 Months : -

Guru Rank Number : 150

Guru Rank Value : 6.9

Guru Occurances : 2


6 Months 1 Year 2 Year

Company Profile Regeneron Pharmaceuticals is a biotechnology company that discovers, invents, develops, manufactures, and commercializes medicines for serious diseases. Co.'s products include: EYLEA (aflibercept) Injection, which is used for the treatment of neovascular age-related macular degeneration, diabetic macular edema, macular edema following retinal vein occlusion, myopic choroidal neovascularization, diabetic retinopathy, and neovascular glaucoma; REGEN-COV, which is used for the treatment of COVID-19; and Kevzara (sarilumab) Solution for Subcutaneous Injection, which is used for the treatment of rheumatoid arthritis.

D/I:

D is for direct shares.
I is for indirect shares.

D/I refers to the Direct or Indirect shares traded vs. held.

Forms:

A Form 4 is a form filed by an insider to indicate a change in ownership.

A Form 3 is a form filed by an insider to indicate an initial ownership of a security.

3m +/-:

This represents the company's 3 month price change. The initial price is based on the closing price of the stock on the day the transaction took place. Purchases & sales are viewed as long & short positions respectively.

Actions:

B	Buy
S	Sell
OE	Option Exercised
A	Acquired
D	Disposed
AB	Automatic Buy
AS	Automatic Sell
IO	Initial Ownership

Download:

Download only Transactions Forms. (Default)

Download only Summary Infomation.

Download both Transactions and Summary Data

Summary (Direct Transactions Only)	3 Months	6 Months	12 Months	24 Months
Total Shares Bought	0	0	0	0
Total Buy Value	$0	$0	$0	$0
Total People Bought	0	0	0	0
Total Buy Transactions	0	0	0	0
Total Shares Sold	192,108	255,165	311,759	469,743
Total Sell Value	$188,697,290	$247,812,013	$294,950,701	$405,465,351
Total People Sold	7	14	16	18
Total Sell Transactions	18	43	67	128
End Date	2024-03-31	2023-12-29	2023-06-30	2022-06-30

Adjust Filter Settings

Records found: 2430

Page 43 of 98

Filer's Name

Relation Title

Off-Dir-10%

D/I

Rank

3m +/-

Form

• • •

2017-08-24

4

B

$474.86

$51,009,572

I/I

105,820

23,808,159

2.64

-

• • •

2017-08-23

4

B

$475.97

$29,024,050

I/I

60,595

23,702,339

2.64

-

Landry Robert E

SVP Finance & CFO

• – –

2017-08-23

4

AS

$474.14

$222,981

D/D

(468)

7,099

-

Landry Robert E

SVP Finance & CFO

• – –

2017-08-22

4

D

$476.10

$729,385

D/D

(1,532)

7,567

-

Landry Robert E

SVP Finance & CFO

• – –

2017-08-22

4

OE

$272.70

$545,400

D/D

2,000

9,099

-

Chairman of the Board

• • –

2017-08-22

4

S

$470.64

$15,257,816

D/D

(31,944)

329,543

-

Chairman of the Board

• • –

2017-08-21

4

S

$470.23

$11,414,076

D/D

(24,269)

361,487

-

Chairman of the Board

• • –

2017-08-18

4

S

$470.15

$1,363,435

D/D

(2,900)

385,756

-

Chairman of the Board

• • –

2017-08-17

4

S

$470.00

$613,350

D/D

(1,305)

388,656

-

Chairman of the Board

• • –

2017-08-16

4

S

$470.17

$5,165,288

D/D

(10,986)

389,961

-

Chairman of the Board

• • –

2017-08-16

4

D

$471.41

$38,921,967

D/D

(82,565)

400,947

-

Chairman of the Board

• • –

2017-08-16

4

OE

$21.92

$3,375,000

D/D

153,969

483,512

-

Chairman of the Board

• • –

2017-08-16

4

GD

$0.00

$0

D/D

84,613

329,543

-

Terifay Robert J

EVP Commercial

• – –

2017-08-10

4

OE

$52.03

$99,950

D/D

1,921

25,214

-

Landry Robert E

SVP Finance & CFO

• – –

2017-08-08

4

AS

$469.91

$248,372

D/D

(526)

7,099

-

Landry Robert E

SVP Finance & CFO

• – –

2017-08-07

4

D

$466.98

$688,329

D/D

(1,474)

7,625

-

Landry Robert E

SVP Finance & CFO

• – –

2017-08-07

4

OE

$272.70

$545,400

D/D

2,000

9,099

-

Yancopoulos George

President and CSO

• • –

2017-08-03

4

GD

$0.00

$0

I/I

176,223

155,406

-

Yancopoulos George

President and CSO

• • –

2017-08-03

4

GA

$0.00

$0

I/I

176,223

176,223

-

Yancopoulos George

President and CSO

• • –

2017-07-21

4

GA

$0.00

$0

I/I

176,223

331,629

-

Yancopoulos George

President and CSO

• • –

2017-07-21

4

GD

$0.00

$0

I/I

176,223

323,777

-

Chairman of the Board

• • –

2017-07-03

4

GD

$0.00

$0

I/I

422

150,285

-

Aberman Michael S

SVP Strategy Investor Relation

• – –

2017-06-22

4

AS

$525.21

$1,208,061

D/D

(2,269)

4,693

-

EVP Research and Development

• – –

2017-06-22

4

AS

$521.70

$4,423,332

D/D

(8,306)

23,950

-

Aberman Michael S

SVP Strategy Investor Relation

• – –

2017-06-21

4

D

$510.02

$1,137,855

D/D

(2,231)

6,962

-

2430 Records found	Previous 40 41 42 43 44 45 46 47 48 49 Next	Page 43 of 98

	Transaction Code Key:				Ownership Code Key
	B	- Buy	AB	- Automatic Buy	D	- Direct Ownership
	S	- Sell	AS	- Automatic Sell	I	- Indirect Ownership
	OE	- Options Exercised	A	- Acquired
	IO	- Initital Ownership	D	- Disposed

Copyright © 2024 j3sg.com | Disclaimer & Terms of use Products & Service About Us Contact Us

Summary:

Chart:

3m +/-:

This represents the company's 3 month price change. The initial price is based on the closing price of the stock on the day the transaction took place. Purchases & sales are viewed as long & short positions respectively.